A multi-state player with a growing presence
- Four fully operational dispensaries: 3 Health for Life dispensaries and The Holistic Center (acquired March 5, 2018)
- The Holistic Center
- Construction of first of three dispensaries underway
- Cultivation and processing facility in Falls River under construction
- Operates fully licensed cultivation, production and wholesale cannabis business GreenMart
- Managing three dispensaries and one (not yet operational) production facility
- Options to acquire each facility
We’re pursuing a multi-state strategy in the U.S., replicating our successful Arizona operations to expand via organic growth and a roll-up strategy.
MPX Bioceutical Corporation’s operations are fully scalable, and will allow the company to increase production in sync with consumer demand and exploit economies of scale
MPX Bioceutical Corporation has access to both generic and proprietary plant varieties to unique products with varying CBD and THC levels
MPX Bioceutical Corporation has access to production techniques and technologies that increase production yields and lower costs
Getting ready for recreational legalization in October 2018
MPX Bioceutical Corporation is developing a 72,342 square foot production facility in Owen Sound, Ontario. Future expansion allows for up to an additional 402,658 square feet for a total of 475,000 square feet.
Once complete, and fully operational, the facility will produce approximately 17,700 lbs (8045 kg) per year of dried flower and 700 lbs (317 kg) of concentrate from byproduct trim.
MPX Bioceutical Corporation anticipates being ready to begin cultivation at its Owen Sound, Ontario facility in the second half of 2018.
CANADIAN SECURITIES EXCHANGE: MPX
MPX Bioceutical Corporation CEO Scott Boyes speaks with The Wall Street analyzer in this podcast on the company’s recent financial results and growth strategy
MPX Q3 Investor Call: March 8, 2018
Chairman, Chief Executive Officer and President
Chief Executive Officer Scott is a seasoned senior executive with diversified and cross-functional experience, combining MBA credentials with a strong career background in revenue development and general management.
Chief Financial Officer
David has over 25 years of senior financial experience, with the past ten spent at the CFO level. He has held positions at Ontario Drive & Gear Limited, Belmont Meats Limited, Redpath Sugar and Nealanders Limited. He holds a Honours Bachelor of Commerce degree from McMaster University and is a CPA.
Chief Operating Officer
Beth Stavola is also the Founder and CEO of Stavola Medical Marijuana Holdings, Health for Life Inc, GreenMart of Nevada, and CBD For Life, thriving cannabis businesses that process, grow and dispense throughout locations in both Arizona and Nevada. Before entering the cannabis space, Beth was Senior Vice President of Institutional Equity Sales at Jefferies New York.
Vice President Grow Operations
Mr. Krytiuk is currently involved with two growing facilities that operate under MMAR in Ontario.
Executive Vice President Sales & Marketing
Michael Arnkvarn has an extensive management background in the operation of small to medium businesses since his graduation from McGill University in 1977 with a BSc in Agricultural Sciences.
JEREMY S. BUDD
Jeremy S. Budd, lawyer and founder of Budd Law, has been practising corporate and securities law in Toronto, Ontario since 2007. Mr. Budd represents issuers and underwriters in a wide variety of capital market transactions. Mr. Budd obtained his J.D./M.B.A. from Osgoode Hall, Law School and the Schulich School of Business at York University in 2005 and holds a Bachelor of Arts in philosophy from Huron University College at the University of Western Ontario.
Vice President Accounting
Jonathan Chu has a strong track record in financial management having held various senior financial accounting positions. Jonathan holds a CPA, CA and a B.Comm from McGill University.
Board of Directors
Scott Boyes is a seasoned senior executive with diversified and cross-functional experience, combining MBA credentials with a strong career background in revenue development and general management.
Randy has extensive experience in finance & operations, centered in the Financial services, real estate and nutraceutical sectors. He has previously served as the CFO of the MPX Bioceutical Corporation and has experienced first handed the evolution of the company. He is presently self-employed and is a CPA, CMA along with a MBA from the University of Toronto.
Beth Stavola is the Founder and CEO of Stavola Medical Marijuana Holdings, Health for Life Inc, GreenMart of Nevada, and CBD For Life, thriving cannabis businesses that process, grow and dispense throughout locations in both Arizona and Nevada. Before entering the cannabis space, Beth was Senior Vice President of Institutional Equity Sales at Jefferies New York.
ANDREW R. RYAN
Andrew Ryan has been General Counsel and a member of the Executive Committee at Holtec International since 2014.
Andrew is responsible for all legal matters affecting Holtec and its subsidiaries as well as insurance and risk management oversight, regulatory compliance, human resources and corporate administration. Prior to joining the executive team of Holtec, Mr. Ryan was an attorney with Lauletta Birnbaum, LLC.
SENATOR RICHARD S. “TICK” SEGERBLOM
Senator Tick Segerblom, State Senator of the Nevada State Senate since November 2012, is widely recognized as a leading legislator in Nevada, and the United States, in the medical and recreational marijuana fields.
Senator Segerblom, age 69, authored Nevada’s 2013 Medical Marijuana law and was Co-Chair of the successful 2016 ballot initiative campaign which approved recreational marijuana in the state.
ROBERT R. GALVIN
Robert Galvin has been CFO and Senior VP of Finance and Administration at Holtec International, an energy technology company, since 2016.
Prior to joining Holtec, Robert served as CFO of several companies, including NuCO2, a NASDAQ company providing bulk CO2 equipment and services. Mr. Galvin is experienced with mergers & acquisitions, debt and equity financings, and SEC compliance. He is a CPA, a Director and Audit Chair for OneSource Water, and a Director and former Stewardship Chair for the New Jersey Juvenile Diabetes Research Foundation.
DR. MILES D. THOMPSON
Dr. Thompson, Ph.D., Project Scientist at Department of Pediatrics, University of San Diego, California since 2016, will advise and assist with the development of cannabinoid-based nutraceutical products. Dr. Thompson served as a Clinical Research Associate at North York General Hospital in Toronto and initiated the study of cannabinoids in epilepsy at the Department of Pharmacology and Toxicology at the University of Toronto. He has extensive experience in the design and implementation of clinical trials administered by Health Canada.
Mr. Petch has 30 + years of senior management, strategic planning and financial analysis experience, including both buy-side and sell-side capital markets experience.
Mr. Petch spent 15 years at Dresdner Kleinwort Benson advising companies on strategy and fundraising including leading a number of successful IPOs, acquisitions and disposals.
Mr. Petch is a Chartered Accountant, and has an honours degree in Engineering Science from Oxford University.